← k3vl4r
Log inGet started →

MIRM (Mirum Pharmaceuticals) Price Forecast

AI-generated price forecast for Mirum Pharmaceuticals (MIRM) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads MIRM as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 82.93. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

82.93

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

MIRM forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▼ Down-8.18%—
Weekly~1.7 years out▼ Down-43.31%—

Latest MIRM news

From the market-news feed the forecasts are read against.

  • Mirum Pharmaceuticals' Brevlovitug Hits Phase III Endpoint in Hepatitis Delta Study · Yahoo · Oct 2
  • Citigroup Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $160 · Benzinga · Sep 29
  • MIRM Stock Gets Increased EPS Forecast from HC Wainwright · ldr:marketbeat.com · Sep 29
  • HC Wainwright Issues Positive Forecast for MIRM Earnings · ldr:americanbankingnews.com · Sep 29
  • Is Mirum Pharmaceuticals (MIRM) Undervalued On New Brelo Vitug Trial Data? · Yahoo · Sep 29

🔒

See the full MIRM forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

MIRM forecast — frequently asked

Will MIRM go up?

K3vl4r's AI model currently reads MIRM as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the MIRM price prediction for 2026?

K3vl4r's model projects MIRM toward $82.86 over the next ~3 months, a -0.1% move from $82.93. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could MIRM reach?

Over its longest horizon (~~1.7 years), the model's projected target for MIRM is $82.57 (-0.4% vs $82.93). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

OSURCRMDQNCXZBIOZVRAEWTXIARTPTGXGRCECPHIPROKATECINDPSNN

Will MIRM reach…?

Will MIRM reach $100.00?Will MIRM reach $200.00?Will MIRM reach $250.00?Will MIRM reach $500.00?

Or see the full MIRM price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare MIRM

MIRM vs OSURMIRM vs CRMDMIRM vs QNCXMIRM vs ZBIOMIRM vs ZVRAMIRM vs EWTX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.